Anna G. Orlova

Ul'yanov Street, 46, 603950
Velikiy Novgorod, NGR, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 227 publications

Imaging of ROR1 expression in tumors using radiolabeled affibody molecules.

Imaging of ROR1 expression in tumors using radiolabeled affibody molecules.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 08, 2026

Near-infrared spectroscopy for urine-based cancer detection: a systematic characterization of the analytical challenges of a complex biofluid matrix.

Near-infrared spectroscopy for urine-based cancer detection: a systematic characterization of the analytical challenges of a complex biofluid matrix.

Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Published: June 02, 2026

Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [177Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.

Experimental radiotherapy with the gastrin-releasing peptide receptor (GRPR) antagonist [177Lu]Lu-AU-SAR-M1 in a prostate cancer murine model using reduced-frequency dosing.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 27, 2026

Integrating Tumor Targeting and Half-Life Extension into a Dual-Surfaced Single-Domain ADAPT Protein.

Integrating Tumor Targeting and Half-Life Extension into a Dual-Surfaced Single-Domain ADAPT Protein.

Journal: Molecular pharmaceutics

Published: May 14, 2026

The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1.

The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1.

Journal: Molecular pharmaceutics

Published: March 04, 2026

Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging.

Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging.

Journal: EJNMMI radiopharmacy and chemistry

Published: January 15, 2026

Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.

Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.

Journal: Journal of biological engineering

Published: January 13, 2026

Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model.

Efficient 68Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model.

Journal: International journal of molecular sciences

Published: December 29, 2025

Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order.

Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order.

Journal: International journal of biological macromolecules

Published: November 13, 2025

Assessing axitinib-induced differential responses in tumor vascularization and oxygenation with combined optoacoustic angiography and diffuse optical spectroscopy.

Assessing axitinib-induced differential responses in tumor vascularization and oxygenation with combined optoacoustic angiography and diffuse optical spectroscopy.

Journal: Neoplasia (New York, N.Y.)

Published: September 27, 2025

Assessment of the angiogenic potential of xenografted tumors by biomedical imaging techniques.

Assessment of the angiogenic potential of xenografted tumors by biomedical imaging techniques.

Journal: Biomedical optics express

Published: September 04, 2025

Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.

Improving GRPR-targeting peptides for radiotheranostics application: insights from chelator modifications and α-methyl-L tryptophan substitution.

Journal: EJNMMI radiopharmacy and chemistry

Published: September 04, 2025

Showing 1-12 of 227

Last Updated: 09/26/2026